Abstract
Onychogryphosis is a disorder of nail plate growth that is clinically characterized by an opaque, yellow-brown thickening of the nail plate with associated gross hyperkeratosis, elongation, and increased curvature. It is most common in older adults and patients with poor personal care. It is a relatively common and important condition because patients may suffer from pain, secondary complications, and cosmetic concerns. We present the case of a 67-year-old man with a 30-year history of severe thickening, abnormal growth, and yellow discoloration of his left great toenail, clinically consistent with onychogryphosis. This review highlights the etiology, diagnosis, and treatment options for onychogryphosis.
References
1.
Chang P, Meaux T: Onychogryphosis: a report of ten cases. Skinmed 2015; 13: 355–359.
2.
Singh G, Haneef NS, Uday A: Nail changes and disorders among the elderly. Indian J Dermatol Venereol Leprol 2005; 71: 386–392.
3.
Zaias N: The Nail in Health and Disease. Springer Science & Business Media, 2012.
4.
Oka H, Asakage Y, Inagawa K, Moriguchi T, Hamasaki T: Free vascularized nail grafts for onychogryphosis of bilateral thumbnails after burn injury. Burns 2002; 28: 273–275.
5.
Nakagami G, Takehara K, Kanazawa T, Miura Y, Nakamura T, Kawashima M, Tsunemi Y, Sanada H: The prevalence of skin eruptions and mycoses of the buttocks and feet in aged care facility residents: a cross-sectional study. Arch Gerontol Geriatr 2014; 58: 201–204.
6.
Barlow AM, Braid SJ, Jayson MI: Foot problems in the elderly. Clin Rehabil 1990; 4: 217–222.
7.
Ebrahim SB, Sainsbury R, Watson S: Foot problems of the elderly: a hospital survey. Br Med J (Clin Res Ed) 1981; 283: 949–950.
8.
Baran R, de Berker DA, Holzberg M, Thomas L (eds): Baran and Dawber’s Diseases of the Nails and Their Management. John Wiley & Sons, 2012.
9.
Sequeira JH: Case of congenital onychogryphosis. Proc R Soc Med 1923; 16(Dermatol Sect):92.
10.
Nath AK, Udayashankar C: Congenital onychogryphosis: Leaning Tower nail. Dermatol Online J 2011; 17: 9.
11.
Lipner SR, Scher RK: Congenital malalignment of the great toenails with acute paronychia. Pediatr Dermatol 2016; 33:e288–e289.
12.
Pahwa P, Lamba AK, Faraz F, Tandon S: Haim-Munk syndrome. J Indian Soc Periodontol 2010; 14: 201–203.
13.
Han XC, Zheng LQ, Zheng TG: Onychogryphosis in tuberous sclerosis complex: an unusual feature. An Bras Dermatol 2016; 91: 116–118.
14.
Hattab FN, Amin WM: Papillon-Lefèvre syndrome with albinism: a review of the literature and report of 2 brothers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 709–716.
15.
Biswas P, Abhishek D, Sendur S, Nag F, Saha A, Chatterjee G: A case of ichthyosis hystrix: unusual manifestation of this rare disease. Indian J Dermatol 2014; 59: 82–84.
16.
Mohammad A: Unusual manifestations of ectodermal dysplasia-syndactyly syndrome type I in two Yemeni siblings. Dermatol Online J 2015; 21.
17.
Freiberg A, Dougherty S: A review of management of ingrown toenails and onychogryphosis. Can Fam Physician 1988; 34: 2675–2681.
18.
Müller C: On the causes of congenital onychogryphosis. Münch Med Wochenschr 1904; 49: 2180–2182.
19.
Barkhordari K, Shafiee A: Ram’s horn nail in lower-limb ischemia. J Tehran Heart Cent 2015; 10: 163–164.
20.
Harada K, Yamaguchi M, Watanabe S, Shimada S: Onychogryphosis by an elastic wire. J Dermatol 2013; 40: 1055–1056.
21.
Kouskoukis CE, Scher RK: Onychogryphosis. J Dermatol Surg Oncol 1982; 8: 138–140.
22.
Ferreira MG, Fattori KR, Souza F, Lima VM: Potential role for dog fleas in the cycle of Leishmania spp. Vet Parasitol 2009; 165: 150–154.
23.
Alvar J, Canavate C, Molina R, Moreno J, Nieto J: Canine leishmaniasis. Adv Parasitol 2004; 57: 1–88.
24.
Moreno J, Alvar J: Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol 2002; 18: 399–405.
25.
Mc Dermott R, Kidney R: Celtic tiger: a case of onychogryphosis. Int J Case Rep Imag 2012; 3: 27–29.
26.
Wagner G, Sachse MM: Congenital malalignment of the big toe nail. J Dtsch Dermatol Ges 2012; 10: 326–330.
27.
Chelidze K, Lipner SR: In the toolbox: the dual action nail clipper. Dermatol Surg 2017, Epub ahead of print.
28.
Möhrenschlager M, Wicke-Wittenius K, Brockow K, Bruckbauer H, Ring J: Onychogryphosis in elderly persons: an indicator of long-standing poor nursing care? Report of one case and review of the literature. Cutis 2001; 68: 233–235.
29.
Yang TH, Tsai HH: Performing cryotherapy on onychogryphotic nails before nail trimming. J Am Acad Dermatol 2016; 75:e69–e70.
30.
Fowler AW: Excision of the germinal matrix: a unified treatment for embedded toe-nail and onychogryphosis. Br J Surg 1958; 45: 382–387.
31.
Greig JD, Anderson JH, Ireland AJ, Anderson JR: Simple avulsion of onychogryphotic toenails: a justifiable treatment? Postgrad Med J 1989; 65: 741–742.
32.
Zhang H, Deng Q: The application of the germinal matrix, nail bed and nail plate ablation to cure the relapse onychogryphosis. Xinjiang Yi Xue Yuan 2010; 6: 034.
33.
Ceilley RI, Collison DW: Matricectomy. J Dermatol Surg Oncol 1992; 18: 728–734.
34.
Zadik FR: Obliteration of the nail bed of the great toe without shortening the terminal phalanx. Bone Joint J 1950; 32: 66–67.
35.
Gürbüz K, Ozan F, Kayali C, Altay T: Total matricectomy and VY advancement flap technique in the treatment of onychogryphosis. Dermatol Surg 2017; 43: 583–586.
36.
Townsend AC, Scott PJ: Ingrowing toenail and onychogryphosis. Bone Joint J 1966; 48: 354–358.
37.
Andrew T, Wallace WA: Nail bed ablation – excise or cauterise? A controlled study. Br Med J 1979; 1: 1539.
38.
Kaplan I, Labandter H: Onychogryphosis treated with the CO2 surgical laser. Br J Plast Surg 1976; 29: 102–103.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.